A phaseIII study of IRESSA treatment beyond progression in addition to Chemotherapy versus Chemotherapy alone

Update Il y a 4 ans
Reference: EUCTR2011-004942-16

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate Progression Free Survival (PFS) in patients who have ‘‘acquired resistance’’ to first line gefitinib


Inclusion criteria

  • non-small cell lung cancer